These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 1861635

  • 1. Insulin resistance in multiple aspects of intermediary metabolism in myotonic dystrophy.
    Krentz AJ, Williams AC, Nattrass M.
    Metabolism; 1991 Aug; 40(8):866-72. PubMed ID: 1861635
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impaired glucose tolerance in obesity is associated with insensitivity to insulin in multiple aspects of metabolism as assessed by a low dose incremental insulin infusion technique.
    Robertson DA, Singh BM, Nattrass M.
    Diabet Med; 1991 Oct; 8(8):718-25. PubMed ID: 1838062
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of morbid obesity on insulin clearance and insulin sensitivity in several aspects of metabolism as assessed by low-dose insulin infusion.
    Robertson DA, Singh BM, Hale PJ, Nattrass M.
    Metabolism; 1992 Jun; 41(6):604-12. PubMed ID: 1640847
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
    Robertson DA, Singh BM, Nattrass M.
    Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
    [Abstract] [Full Text] [Related]

  • 9. Basal intermediary metabolism in impaired glucose tolerance and morbid obesity.
    Krentz AJ, Singh BM, Hale PJ, Robertson DA, Nattrass M.
    Diabetes Res; 1992 Oct; 20(3):51-60. PubMed ID: 1345002
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Decreased insulin sensitivity of forearm muscle in myotonic dystrophy.
    Moxley RT, Griggs RC, Goldblatt D, VanGelder V, Herr BE, Thiel R.
    J Clin Invest; 1978 Oct; 62(4):857-67. PubMed ID: 701484
    [Abstract] [Full Text] [Related]

  • 12. Hyperproinsulinaemia in patients with myotonic dystrophy.
    Krentz AJ, Clark PM, Cox L, Williams AC, Nattrass M.
    Diabetologia; 1992 Dec; 35(12):1170-2. PubMed ID: 1478370
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Abnormal regulation of carbohydrate metabolism in motor neurone disease.
    Krentz AJ, Williams AC, Nattrass M.
    Diabetes Res; 1991 Feb; 16(2):93-9. PubMed ID: 1817811
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The direct relationship of proinsulin-insulin hypersecretion to basal serum levels of cholesterol and triglyceride in myotonic dystrophy.
    Poffenbarger PL, Bozefsky T, Soeldner JS.
    J Lab Clin Med; 1976 Mar; 87(3):384-96. PubMed ID: 765416
    [Abstract] [Full Text] [Related]

  • 19. Lack of rapid enhancement of insulin action after oral glucose challenge in myotonic dystrophy.
    Moxley RT, Kingston WJ, Griggs RC, Livingston JN.
    Diabetes; 1987 Jun; 36(6):693-701. PubMed ID: 3552801
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.